Add Yahoo as a preferred source to see more of our stories on Google. Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being ...

Adults hospitalized with an acute respiratory syncytial virus (RSV) infection faced an increased risk of cardiorespiratory events such as heart attack or stroke in the weeks afterward, according to a ...

Infectious disease experts are dismayed that the monoclonal antibody against respiratory syncytial virus (RSV) for infants, widely considered a crucial advance in public health, has been downgraded on ...

A single dose of the recombinant respiratory syncytial virus (RSV) vaccine demonstrates effectiveness against infections and associated hospitalizations in veterans aged 60 years or older during the ...

Level of risk peaked in the week after a hospital admission but lingered through 6 months ...

Universal nirsevimab prophylaxis is linked to fewer respiratory syncytial virus cases and milder disease in infants, real-world evidence from Italy shows.

This article is part of “Innovations In: RSV,” an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca. Susan Green developed a stubborn ...

This video is part of “Innovations In: RSV," an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca. Zachary Rubin: Holy cow, folks. We’re ...

The season of never-ending sneezing and stuffy noses is underway, sending Americans to pharmacy lines in hopes of keeping illness at bay with yearly shots. While flu and COVID-19 vaccines are an ...